| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $354.6M | — | +7.2% |
| Cost of Revenue | $98.3M | — | -7.7% |
| Gross Profit | $256.3M | — | +14.3% |
| R&D Expense | $67.8M | — | +10.3% |
| SG&A Expense | $31.1M | — | +21.9% |
| Operating Income | $103.0M | — | +23.9% |
| Pre-tax Income | $92.4M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $265.4M | -16.8% | -7.8% |
| Accounts Receivable | $122.0M | -1.4% | +4.9% |
| Current Assets | $466.5M | -8.9% | -1.3% |
| Total Assets | $3.31B | -2.2% | -3.2% |
| Current Liabilities | $135.7M | -13.5% | +16.7% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $97.5M | — | +50.6% |
| Capital Expenditures | $362K | — | +320.9% |
| Investing Cash Flow | -$13.9M | — | +13.9% |
| Financing Cash Flow | -$137.2M | — | -142.2% |
| Free Cash Flow | $97.2M | — | +50.3% |
| +30.2% |
| Income Tax | $23.0M | — | +35.0% |
| Net Income | $69.4M | — | +28.8% |
| EPS (Basic) | $0.82 | — | +32.3% |
| EPS (Diluted) | $0.82 | — | +34.4% |
| $942.7M |
| -1.5% |
| -10.8% |
| Total Liabilities | $1.26B | -1.1% | -2.6% |
| Stockholders' Equity | $2.05B | -2.8% | -3.6% |